Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)
20 Outubro 2021 - 5:09PM
Edgar (US Regulatory)
NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b)
OF THE SECURITIES EXCHANGE ACT OF 1934.
| |
Commission File Number
001-38723 |
|
Issuer: | Tiziana Life Sciences plc |
Exchange: | Nasdaq Stock Market LLC |
(Exact name of Issuer as specified in its charter, and name of
Exchange where security is listed and/or registered)
|
|
Address: | 9th Floor, 107 Cheapside London, UNITED KINGDOM EC2V 6DN |
Telephone number: | +44 (0) 207 495 2379 |
(Address, including zip code, and telephone number, including area code, of Issuer's
principal executive offices)
|
|
Tiziana Life Sciences plc American Depositary Shares |
(Description of class of securities)
|
|
Please place an X in the box to designate the rule provision relied upon to strike
the class of securities from listing and registration:
|
o 17 CFR 240.12d2-2(a)(1) |
o 17 CFR 240.12d2-2(a)(2) |
x 17 CFR 240.12d2-2(a)(3) |
o 17 CFR 240.12d2-2(a)(4) |
o
Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange.
1 |
o
Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.
|
|
Pursuant to the requirements for the Securities Exchange Act of 1934,
Nasdaq Stock Market LLC
certifies that it has reasonable grounds to believe that it
meets all of the requirements for filing the Form 25 and has caused this notification to be
signed on its behalf by the undersigned duly authorized person.
|
|
2021-10-20 | By | Tara Petta | | AVP - Securities Operations |
Date
| | Name | | Title |
|
1 |
Form 25 and attached Notice will be considered compliance with the provisions of
17 CFR 240.19d-1 as applicable. See General Instructions.
Tiziana Life Sciences (NASDAQ:TLSA) Gráfico Histórico do Ativo De Abr 2024 até Mai 2024
Tiziana Life Sciences (NASDAQ:TLSA) Gráfico Histórico do Ativo De Mai 2023 até Mai 2024
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Segunda, 13 de Maio de 2024 (2 semanas atrás) • Edgar (US Regulatory) |
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Sexta, 10 de Maio de 2024 (2 semanas atrás) • Edgar (US Regulatory) |
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Terça, 5 de Março de 2024 (3 meses atrás) • Edgar (US Regulatory) |
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Segunda, 8 de Janeiro de 2024 (5 meses atrás) • Edgar (US Regulatory) |
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Sexta, 5 de Janeiro de 2024 (5 meses atrás) • Edgar (US Regulatory) |
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Sexta, 5 de Janeiro de 2024 (5 meses atrás) • Edgar (US Regulatory) |
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Sexta, 29 de Dezembro de 2023 (5 meses atrás) • Edgar (US Regulatory) |
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Terça, 19 de Dezembro de 2023 (5 meses atrás) • Edgar (US Regulatory) |
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Segunda, 4 de Dezembro de 2023 (6 meses atrás) • Edgar (US Regulatory) |
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Sexta, 1 de Dezembro de 2023 (6 meses atrás) • Edgar (US Regulatory) |
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Quinta, 30 de Novembro de 2023 (6 meses atrás) • Edgar (US Regulatory) |
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] Quarta, 1 de Novembro de 2023 (7 meses atrás) • Edgar (US Regulatory) |
Mais Notícias de Tiziana Life Sciences Plc
Parece que você não está logado. Clique no botão abaixo para se logar e ver seu histórico recente.
|